Peninsula Group Announces New £3M Charity Partnerships
MANCHESTER, England–(BUSINESS WIRE)–Manchester-based global employment law and HR consultancy, Peninsula Group, has today announced a new three-year,... Read more.
The Upgraded Regula 4205D: Forensic-Level Document Verification for Border Security
In the face of continually increasing migration flows, Regula constantly enhances its document verification potential to facilitate ID processing at border control... Read more.
Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE:... Read more.
Ryan Announces Integration with SAP® Concur® Solutions
Integration Allows Automatic Export into Tax Compliant Software for Ryan’s Global End-Customers LONDON–(BUSINESS WIRE)–Ryan, a leading global tax services... Read more.
Positive Feedback From the EMA and FDA on Alzprotect’s Phase 2b/3 Development Strategy for PSP
LILLE, France–(BUSINESS WIRE)–ALZPROTECT is thrilled to announce that it has received favorable feedback from both the American (FDA) and European (EMA)... Read more.
Trellix Safeguards Sensitive and Proprietary Information with New Protections for macOS
New Trellix Data Loss Prevention Endpoint Complete capabilities secure customers from data leaks and insider threats SAN JOSE, Calif.–(BUSINESS WIRE)–Trellix,... Read more.
Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003
– Program update includes 4-month durability data from Phase 2 trial of CYB003 in Major Depressive Disorder (“MDD”) – – Company speakers... Read more.
GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 14,000,000 Shares
CHICAGO–(BUSINESS WIRE)–GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the... Read more.
Gibbs Law Group Files Class Action Lawsuit on Behalf of Consumers Harmed by Change Healthcare Data Breach
Lawsuit Alleges Change Healthcare Failed to Protect Millions of Patients’ Sensitive Health Information OAKLAND, Calif.–(BUSINESS WIRE)–On March 12,... Read more.
InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune... Read more.